Women’s Health Update: Hormone-Free Contraceptive, HIV Shot Approved, CDC Shake-Up and More
From non-hormonal contraception approvals to FDA milestones in HIV prevention and bold global initiatives, this week’s Women’s Health Update delivers the most impactful developments across reproductive health, autoimmune disease, mental health, and public policy.
🔬 Key highlights:
💪 Weak muscle strength and high visceral fat increase diabetes risk 2.63x in midlife women
💧 Europe approves Inne’s saliva-based, hormone-free contraceptive with perfect-use effectiveness
🧠 AAP urges adolescent-focused contraceptive care and expands access via telehealth and pharmacies
⚠️ UK MHRA warns GLP-1 drugs like Mounjaro may reduce oral contraceptive efficacy
🩸 Endometriosis genetically linked to MS, coeliac disease, and rheumatoid arthritis
💉 FDA approves Yeztugo: twice-yearly HIV prevention shot with greater than 99.9 percent efficacy
🌍 WHO issues first global pregnancy care guidelines for sickle cell disease
🧪 Psilocybin drug hits Phase 3 depression target, but stock dips 36% amid investor caution
👟 Serena Williams to mentor 200 women-led health startups across 12+ countries by 2030
🧬 RFK Jr. overhauls CDC vaccine panel, cancels HPV review, raising concerns over public health governance
📢 Stay Ahead in Women’s Health Research!
✅ Like, share, and subscribe for weekly updates on women’s health, reproductive medicine, neurology, and global public health
#WomensHealth #ReproductiveHealth #HIVPrevention #SickleCell #Endometriosis #GLP1Drugs #ContraceptiveCare #PsychedelicMedicine #CDC #SerenaWilliams #LucidQuest #PublicHealth #MedicalNews #HealthcareInnovation #ClinicalTrials